ARCA biopharma declares special dividend of $1.59/share in connection with proposed Oruka merger

Oruka Therapeutics, Inc.

Special dividend estimated at $1.59 per share, payable to stockholders of record as of August 26, 2024.
Dividend payment date scheduled for August 28, 2024, subject to stockholder approval of the Oruka merger.
Merger vote at special meeting on August 22, 2024; merger close expected August 29, 2024.
Dividend amount based on ARCA's net cash exceeding $5M; actual amount may vary.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.